Skip to main content

Eliem Therapeutics begins trading on Nasdaq, raising $80M

The Redmond-based company joins a growing list of Seattle-area biotechs that have gone public in recent years, including Sana Biotechnology and Adaptive Biotechnologies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.